Anne Lesage - 22 Apr 2026 Form 4 Insider Report for Pharvaris N.V. (PHVS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Apr 2026, 12:18:10 UTC
Prior SEC filing
18 Mar 2026
Next SEC filing
01 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marnus Nel, Attorney-in-Fact for Anne Lesage

Key filing fact

Anne Lesage filed Form 4 for Pharvaris N.V. (PHVS) on 24 Apr 2026.

Key facts

  • This page summarizes Anne Lesage's Form 4 filing for Pharvaris N.V. (PHVS).
  • 11 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 24 Apr 2026, 12:18.

Change

  • Previous filing in this sequence was filed on 18 Mar 2026.
  • Current net transaction value: -$441,726.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001973705 Primary reporting owner

Lesage Anne

Relationship
Chief Early Development
Address
1 CRANBERRY HILL SUITE 400, LEXINGTON
Signature
/s/ Marnus Nel, Attorney-in-Fact for Anne Lesage
Signature date
24 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares
+500
Change %
+0.89%
Price
$2.59*
Shares after
56,950
Date
22 Apr 2026
Ownership
Direct
Footnotes
F1
PHVS transaction

Common Stock

Sale

Transaction value
$15,000
Shares
-500
Change %
-0.88%
Price
$30.00
Shares after
56,450
Date
22 Apr 2026
Ownership
Direct
Footnotes
F1
PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares
+7,000
Change %
+12%
Price
$8.05*
Shares after
63,450
Date
22 Apr 2026
Ownership
Direct
Footnotes
F1
PHVS transaction

Common Stock

Sale

Transaction value
$210,362
Shares
-7,000
Change %
-11%
Price
$30.05
Shares after
56,450
Date
22 Apr 2026
Ownership
Direct
Footnotes
F1, F2
PHVS transaction

Common Stock

Sale

Transaction value
$210,358
Shares
-7,000
Change %
-4.3%
Price
$30.05
Shares after
156,969
Date
22 Apr 2026
Ownership
GrayMatters Consulting B.V.
Footnotes
F2
PHVS transaction

Common Stock

Sale

Transaction value
$3,003
Shares
-100
Change %
-0.06%
Price
$30.03
Shares after
156,869
Date
23 Apr 2026
Ownership
GrayMatters Consulting B.V.
PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares
+100
Change %
+0.18%
Price
$2.59*
Shares after
56,550
Date
23 Apr 2026
Ownership
Direct
Footnotes
F1
PHVS transaction

Common Stock

Sale

Transaction value
$3,003
Shares
-100
Change %
-0.18%
Price
$30.03
Shares after
56,450
Date
23 Apr 2026
Ownership
Direct
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-500
Change %
-3%
Price
$0.000000*
Shares after
15,972
Date
22 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500
Exercise price
$2.59
Footnotes
F1, F4
PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-7,000
Change %
-5.8%
Price
$0.000000*
Shares after
113,000
Date
22 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,000
Exercise price
$8.05
Footnotes
F1, F5
PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-100
Change %
-0.63%
Price
$0.000000*
Shares after
15,872
Date
23 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
100
Exercise price
$2.59
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

This is a scheduled exercise and sale from 10b5-1 trading plan.

Footnote F2

These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13.

Footnote F3

These shares were sold in multiple transactions at prices ranging from $30.03 to $31.03.

Footnote F4

25% of the option vested on January 1, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter.

Footnote F5

25% of the option vested on February 5, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .